ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: SA-PO764

Endothelial Cell-Specific G2APOL1 Expression Induces Hypertension via STING and NLRP3 Pathways

Session Information

  • Hypertension and CVD: Mechanisms
    November 05, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
    Abstract Time: 10:00 AM - 12:00 PM

Category: Hypertension and CVD

  • 1503 Hypertension and CVD: Mechanisms

Authors

  • Poudel, Bibek, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
  • Wahba, Joseph, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
  • Vassalotti, Allison, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
  • Raman, Archana, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
  • Wu, Junnan, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
  • Susztak, Katalin, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
Background

Genetic studies showed an association between ApolipoproteinL1 (APOL1) high risk (G1/G2) genotype and hypertension (HTN) and hypertensive kidney disease (H-CKD). The causal role of APOL1 in the development of HTN and H-CKD is not fully understood.

Methods

In the human kidney, APOL1 is highly expressed in endothelial cells and podocytes. We generated endothelial and podocyte-specific inducible G0 and G2 APOL1 transgenic mice by crossing the TRE-G2APOL1 and TRE-G0-APOL1 mice with the endothelial-specific Cdh5tTA and podocyte-specific (NPHS1rtTA) transgenic mice. We induced APOL1 expression by doxycycline diet. In the Cdh5tTA/TRE-G2APOL1 and control mice, we performed uni-nephrectomy (UNX) at five weeks of age and kept mice on a 4% salt diet for 12 weeks. Blood pressure was monitored by the tail-cuff method. To understand the role of the inflammasome (NLRP3 and GSDMD) and the cytosolic nucleotide sensor (STING) in disease development, we crossed the STING, NLRP3, and GSDMD knock-out mice with the Cdh5tTA/TRE-G2APOL1 animals.

Results

Podocyte-specific G2APOL1 transgenic mice developed severe HTN only after proteinuria and renal damage was observed, likely representing a secondary HTN. Systolic, diastolic, and mean arterial blood pressure was mildly but significantly higher in Cdh5tTA/TRE-G2APOL1 mice compared to control mice. Cdh5tTA/TRE-G2APOL1 mice also developed a slight increase in urinary albumin/creatinine ratio and renal fibrosis after the animals became hypertensive. Hypertension, renal fibrosis, and proteinuria were ameliorated in STING, NLRP3, and GSDMD knock-out Cdh5tTA/TRE-G2APOL1 mice compared to Cdh5tTA/TRE-G2APOL1 mice. Our preliminary data indicate an increased cytosolic leakage of mitochondrial DNA in Cdh5tTA/TRE-G2APOL1 mice, which is likely responsible for the STING, NLRP3, and GSDMD activation in the Cdh5tTA/TRE-G2APOL1 mice.

Conclusion

EC-specific G2APOL1 transgenic mice developed mild salt-sensitive hypertension and renal damage, indicating the causal role of G2APOL1 in hypertension and hypertensive kidney disease, while podocyte-specific G2APOL1 was associated with secondary hypertension. This project was supported by DK105821.

Funding

  • NIDDK Support